The Lung Cancer Policy Network operates under a clear governance framework to ensure its activities are independent, evidence-informed and aligned with its mission to make lung cancer survival a global policy priority.

Good governance is not simply a formality. It’s what makes the Network’s outputs credible and its recommendations trustworthy to policymakers.

Independence and transparency

Independence and transparency are central to the Network’s governance:

  • All outputs are non-promotional and evidence-based.
  • Editorial control rests with the Network Secretariat to maintain integrity.
  • Activities comply with relevant regulatory and compliance requirements.
  • Funding arrangements are transparent (see below) and do not influence the content of outputs.

Governance structure

Network members

Members are central to the governance and delivery of all Network activities. They contribute expertise to shape strategic priorities and outputs, participate in meetings and working groups, and bring diverse national and professional perspectives to the Network’s work. All members contribute their time on a voluntary basis.

 

About our members

Steering Committee

The Steering Committee provides strategic oversight and guidance, supporting the development of the Network’s strategic direction, advising on priority topics and workstreams, and ensuring alignment with the Network’s mission and objectives.

  • David Baldwin, University of Nottingham
  • Angela Barry, GO2 for Lung Cancer
  • Joelle Fathi, GO2 for Lung Cancer
  • Catharine Grimes, Bristo Myers Squibb Foundation
  • Maria Isabella Grueso, Pfizer
  • Helen Haggart, Johnson & Johnson
  • Michael Hartevelt, MSD
  • Merel Hennink, Global Lung Cancer Coalition
  • Luciana Holtz, Oncoguia
  • Karen Kelly, International Association for the Study of Lung Cancer (IASLC)
  • Jennifer King, IASLC
  • David LeDuc, AstraZeneca
  • Herbert Loong, The Chinese University of Hong Kong
  • Allona McCloy, MSD
  • Olivia McDermid, Amgen
  • Tracy McDowell, AstraZeneca
  • Linda Murakami, Amgen
  • Morten Quist, University Hospital of Copenhagen, Rigshospitalet
  • Sebastian Schmidt, Siemens Healthineers
  • Victoria Schnieder, Siemens Healthineers
  • Murry Wynes, IASLC

Secretariat

The Secretariat, provided by The Health Policy Partnership, is responsible for delivering all Network activities. It operates independently to ensure the integrity and quality of all Network activities.

Find out more

Network funders

The Network is funded by multiple organisations.

Major funders

Minor funders

Read the full Network Terms of Reference

The full Terms of Reference for the Network can be downloaded by clicking the button below. All Network members agree to the Terms of Reference, and any edits to the these are made by Network members’ consensus.

Lung Cancer Policy Network
Cookie Settings

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.